4//SEC Filing
TYSON TIMOTHY 4
Accession 0001209191-22-051854
CIK 0001556263other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:42 PM ET
Size
7.0 KB
Accession
0001209191-22-051854
Insider Transaction Report
Form 4
TYSON TIMOTHY
Director
Transactions
- Purchase
Common Stock
2022-09-30$6.37/sh+14,000$89,186→ 24,932 total - Purchase
Common Stock
2022-09-29$5.72/sh+2,932$16,770→ 10,932 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.66 to $5.75, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.03 to $6.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001207405
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:42 PM ET
- Size
- 7.0 KB